Amerise Biosciences Fair Value
Amerise Biosciences fair value. Amerise Biosciences (AMERISE) average fair value is ₹11.71 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹0.81 (+1346.3%), fair value range ₹7.14–₹16.29. For live price and a broader fundamental view, visit Amerise Biosciences stock price NSE.
Fair Value Analysis Export
AMERISE Fair Value vs Current Price — Valuation Summary
AMERISE average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation. Explore AMERISE intrinsic value to estimate fundamental worth using multiple valuation models.
P/B Based Valuation
Asset-Based Valuation
AMERISE Fair Value Analysis — Data Sources & Coverage
Amerise Biosciences financial data sources, valuation methods applied and sector benchmarks used. Check AMERISE market capitalization to track the company's total market size over time.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
AMERISE vs Industrial Products Sector Peers — P/E, P/B & Market Cap
Amerise Biosciences P/E ratio, P/B ratio and market capitalisation vs Industrial Products sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Chatterbox Technologies | CHTR | 4.76 | 0.62 | ₹43 |
| Polysil Irrigation Syste… | POLYSIL | 50.94 | 2.9 | ₹138 |
| Smiths & Founders | SMFIL | 69.23 | 14.88 | ₹92 |
| JMG Corporation | JMGCORP | - | 2.17 | ₹14 |
| INTEGRATED THERMOPLASTICS | INTETHR | - | -0.12 | ₹5 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.